Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 295

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 19
Chunk 295
---
 the year ended December 31, 2024 formatted in inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Statements of Financial Position at December 31, 2024 and 2023; (ii) Consolidated Statements of Profit or Loss for the years ended December 31, 2024, 2023 and 2022; (iii) Consolidated Statements of Changes in Equity for the years ended December 31, 2024, 2023 and 2022; (iv) Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022; and (v) Notes to Consolidated Financial Statements, tagged as blocks of text.†
    104   Cover Page Interactive Data File 101                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

†   Filed herewith.
-------------------

^   Furnished herewith.
-----------------------

*   In accordance with the rules of the SEC certain confidential information contained in this exhibit, has been omitted because it (i) is not material and (ii) is the type that the Company treats as private or confidential.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------